TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $677,000 | +83.0% | 9,009 | -34.5% | 0.00% | +100.0% |
| Q1 2022 | $370,000 | -54.3% | 13,760 | -19.1% | 0.00% | -50.0% |
| Q4 2021 | $810,000 | -25.9% | 17,010 | +3.4% | 0.00% | -33.3% |
| Q3 2021 | $1,093,000 | -32.5% | 16,450 | -20.8% | 0.00% | -40.0% |
| Q2 2021 | $1,620,000 | +2.9% | 20,761 | +24.7% | 0.01% | 0.0% |
| Q1 2021 | $1,574,000 | -17.8% | 16,644 | +6.0% | 0.01% | -28.6% |
| Q4 2020 | $1,914,000 | +99.4% | 15,705 | +43.0% | 0.01% | +75.0% |
| Q3 2020 | $960,000 | +43.1% | 10,984 | +5.7% | 0.00% | 0.0% |
| Q2 2020 | $671,000 | +129.0% | 10,392 | +58.5% | 0.00% | +100.0% |
| Q1 2020 | $293,000 | -59.1% | 6,557 | -43.0% | 0.00% | -33.3% |
| Q4 2019 | $717,000 | – | 11,505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |